Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

GSK2251052

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
ABSTRACT The emergence of multidrug-resistant (MDR) Gram-negative bacilli is a major concern in the treatment of nosocomial… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
2016
2016
ABSTRACT GSK2251052 is a broad-spectrum antibacterial inhibitor of leucyl tRNA-synthetase (LeuRS) that has been evaluated in… Expand
  • figure 1
Highly Cited
2014
Highly Cited
2014
ABSTRACT GSK2251052, a novel leucyl-tRNA synthetase (LeuRS) inhibitor, was in development for the treatment of infections caused… Expand
  • table 1
  • table 2
  • table 3
  • table 4
2013
2013
ABSTRACT We studied the comparative in vitro activity of GSK2251052, a novel boron leucyl-tRNA synthetase inhibitor, against 916… Expand
  • table 1
  • table 2
  • table 2
2013
2013
(S)-3-(Aminomethyl)-7-(3-hydroxypropoxy)-1-hydroxy-1,3-dihydro-2,1-benzoxaborole (GSK2251052) is a novel boron-containing… Expand
  • figure 2
  • table 1
  • figure 3
  • table 2
  • figure 4
2013
2013
GSK2251052 is a boron-containing antimicrobial agent in clinical development for the treatment of serious Gram-negative bacterial… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
2013
2013
ABSTRACT The plasma and intrapulmonary pharmacokinetics (PK) of intravenous (i.v.) GSK2251052, a novel boron-containing… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
2013
2013
(S)-3-(Aminomethyl)-7-(3-hydroxypropoxy)-1-hydroxy-1,3-dihydro2,1-benzoxaborole (GSK2251052) is a novel boron-containing… Expand
  • figure 2
  • table 1
  • figure 3
  • table 2
  • figure 4
2013
2013
10 Running Title: Pulmonary and Plasma PK of GSK2251052 11 12 13 # Corresponding author: Parul Patel, Pharm.D. 14 GlaxoSmithKline… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
2011
2011
Background: GSK2251052 (formerly AN3365), a novel boron-containing leucyl-tRNA synthetase inhibitor with in vitro activity… Expand